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Purpose: Previous studies and our own clinical experience suggest that concurrent 
corticosteroid treatment for severe rickettsial disease with multiorgan failure may 
improve the clinical course or reduce mortality. However, the use of corticoste-
roids as adjunctive treatment for rickettsial diseases is controversial. We attempted 
to determine the influences of corticosteroid on the growth of Orientia tsutsuga-
mushi in vitro to justify and evaluate the clinical applicability of corticosteroid in 
rickettsial disease. Materials and Methods: L929 cells were infected with Orien-
tia tsutsugamushi Gilliam. Dexamethasone was added to the cells at final concen-
trations of 101 and 107 pg/mL. Cultures were incubated at 35°C and processed for 
flow cytometry on the 6th day after addition of dexamethasone. Results: Observa-
tion on the 6th day after treatment with dexamethasone in infected cultures re-
vealed that there was no difference in fluorescence intensity among the treatment 
wells. Treatment of the cells with dexamethasone at concentrations of 101 and 107 
pg/mL showed no influence on the growth of Orientia tsutsugamushi. Conclu-
sion: Our results to show that isolated corticosteroid does not enhance the replica-
tion of Orientia tsutsugamushi in vitro. Concurrent use of anti-inflammatory or 
immunosuppressive doses of corticosteroids in conjunction with antibiotics may 
not have detrimental effects on the course of scrub typhus.
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INTRODUCTION
The causative agent of scrub typhus, Orientia tsutsugamushi, is obligate intracellu-
lar bacteria proliferating within eukaryotic cells.1 Several studies on the effect of 
interferon on the growth of rickettsia have been conducted, and interferon-γ has 
been reported to inhibit the growth of rickettsia in vitro; however, its direct effect 
on recovery from acute infection and prevention of recurrence has not yet been 
clearly clarified.2,3 Effect of Steroid on Orientia Tsutsugamushi
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tor maintained at 5% CO2, and the cell proliferation level 
was examined. 
After more than 90% of cells were infected, the cultured 
L929 cells were collected using a scraper and the collected 
cell suspension was disrupted by glass dounce (tight piston, 
Wheaton Inc., Millville, NJ, USA). The disrupted cell solu-
tion was centrifuged at 500×g for 5 min, cell debris was re-
moved, and the supernatant was collected. The supernatant 
was centrifuged at 1,000×g for 10 min. Precipitates were 
collected and resuspended in DMEM medium, aliquoted as 
1 mL, stored at -80°C in liquid nitrogen, and used in the ex-
periments. 
Antibody and indirect immunofluorescence staining  
Anti-Orientia tsutsugamushi Gilliam mouse serum was ob-
tained by injecting C3H mice 2-3 times with rickettsia at 
2-week intervals and sampling after 4 weeks. Using an anti-
Orientia tsutsugamushi Gilliam mouse serum with the titer 
higher than 1 : 640 and FITC-conjuated goat anti-mouse 
IgG (Cappel Laboratories, Cochranville, PA, USA) diluted 
1 : 100 in PBS, rickettsia-infected cells were stained by in-
direct immunofluorescent antibody method and examined 
under a fluorescent microscope (microscope trinocular, 
Olympus, Tokyo, Japan). Infection levels of the L929 cells 
were assessed and flow cytometry (FACSCalibur, Becton 
Dickinson, San Jose, CA, USA) was used to evaluate in-
fected cell proliferation. 
Addition of corticosteroids 
To evaluate the effect of corticosteroids on the proliferation 
of cells themselves, 1 mL DMEM medium containing dexa-
methasone (Sigma Chemical Co., St. Louis, MO, USA) at fi-
nal concentrations of 101, 103, 105, and 107 pg/mL was add-
ed to the L929 cells cultured as a monolayer in six wells 
and by varying the culture period, cell viability level was 
measured by MTT assay and hemocytometer.7 
To examine the effects of rickettsia infection, rickettsia 
suspension was added to L929 cells, cultured at 35°C for 1 
hr, and under the infected conditions, 1 mL DMEM medi-
um with dexamethasone (101 to 107 pg/mL) was added and 
cultured for six days. 
Interferon-γ administration 
Monolayers of L929 cells in 6-well plates (Corning Glass 
Works, Corning, NY, USA) received maintenance DMEM 
medium containing an appropriate amount of interferon-γ 
(Serotec, Oxford, UK) and were incubated for 24 hrs. After 
Supplemental administration of corticosteroids for rick-
ettsial diseases is still controversial, and definitive data to 
substantiate its beneficial or detrimental effects are not suf-
ficient. Physicians can be confronted with the dilemma of 
initiating immunosuppressive corticosteroid treatment in a 
critically ill patient, for which the tentative diagnoses in-
clude immunologically mediated anemia and/or immunity-
mediated thrombocytopenia or severe rickettsial disease.4 
Indeed, in some studies, the simultaneous administration 
of corticosteroid to severe rickettsia-infected patients with 
concomitant multiorgan impairment has been reported to be 
of help to the improvement of the clinical course or reduc-
tion of mortality.4-6 But in a clinical course, the direct effects 
of drugs and many diverse factors may be involved and it is 
difficult to evaluate the pure effect of drugs in clinical stud-
ies. The possibility that corticosteroids could stimulate the 
proliferation of pathogens in some infectious diseases could 
be a limiting factor to the additional administration of corti-
costeroids.4 
Therefore, we objectively evaluated the effects of the ad-
ministration of corticosteroids on the growth rate of Orien-
tia tsutsugamushi in an L929 cell line infected in vitro. 
MATERIALS AND METHODS
Cell culture 
Murine L929 cells provided by the American Type Culture 
Collection (CCL1, Rockville, MD, USA) and kept at the De-
partment of Microbiology and Immunology at Seoul Nation-
al University were obtained and used. L929 cells were cul-
tured in Dulbecco’s modified Eagle’s medium (DMEM, 
Gibco BRL, Grand Island, NY, USA) containing 10% (vol/
vol) fetal bovine serum (FBS), penicillin (100 unit/mL), 
streptomycin (100 μg/mL), and 2 mM L-Glutamine in a 
37°C incubator maintained 5% CO2. When the cells grew 
and covered 80-90% of the bottom of culture flasks, they 
were either infected with rickettsia or a subculture was per-
formed. 
Rickettsia 
In 6-well plates (Corning Glass Works, Corning, NY, USA), 
106 cells per well were added, cultured for 24-36 hr, and 
the L929 cells formed a monolayer that was infected with 
Orientia tsutsugamushi Gilliam at a density of 0.5 particle 
per cell. Subsequently, DMEM medium was added, con-
taining 5% FBS, the cells were incubated in a 35°C incuba-Chang Oh Kim, et al.
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RESULTS
  
Cellular morphology of L929 cells after Orientia 
tsutsugamushi infection and the addition of 
corticosteroids 
Considering the results of previous studies regarding mor-
phological changes of mouse fibroblasts prior to and after 
Orientia tsutsugamushi infection, uninfected L929 cells, 
L929 cells infected with Orientia tsutsugamushi, and L929 
cells treated with corticosteroids after infection were cul-
tured.10 At 24-hr intervals between 24 and 96 hrs, the gross 
morphology of the L929 cells was examined by phase con-
trast microscopy. No differences were detected in the num-
ber of cells or morphology according to the status of Orien-
tia tsutsugamushi infection or corticosteroid doses (Fig. 1). 
 
Alteration of growth of L929 cells according to 
corticosteroid concentration 
To examine the effect of corticosteroids on the proliferation 
of L929 cells to be infected Orientia tsutsugamushi, cells 
were cultured for 10 days with various concentrations of cor-
ticosteroids and the number of cells was checked. The results 
showed that during 1-7 days of culture, cell proliferation was 
not affected by the presence or absence of corticosteroid, nor 
was it influenced by the dosage of corticosteroid (Fig. 2). Af-
ter day 3, it was observed that cell proliferation decreased 
markedly because cells were in a fully saturated state. 
　
Effect of corticosteroid on Orientia tsutsugamushi 
growth? 
Corticosteroid concentration was raised from 101 pg/mL to 
107 pg/mL by 10-fold. The growth level of Orientia tsutsuga-
aspiration of the medium, the cells were inoculated with the 
rickettsia at multiplicity of infection and absorbed for 1 hr 
at 35°C. Unabsorbed rickettsiae were aspirated off, and each 
culture was fed with 1 mL of maintenance medium contain-
ing interferon-γ. Untreated control cultures were inoculated 
with rickettsia and treated with maintenance medium alone. 
Cultures were incubated at 35°C and processed for flow cy-
tometry at various intervals.8  
　
Preparation of samples used for flow cytometry 
The fixation and staining of cells infected with rickettsia was 
performed as suggested in previous studies.8,9 Summarizing 
briefly, after rickettsial infection and addition of corticoste-
roid, cells cultured for a certain time were washed with PBS, 
PBS was added to cell precipitates obtained by the dissocia-
tion of cells using 0.25% trypsin-0.1% etylene-diamine tet-
raacetate-PBS, centrifuged, and resuspended to 106 cells/
mL. Cell precipitates obtained by centrifugation at 5,000 
rpm for 15 sec were resuspended with 4°C PBS 100 μL and 
-30°C methanol 900 μL was added and kept at -30°C for 
more than 15 min. These cells were stored at -30°C until 
staining. As described above, the fixed cells were stained by 
the indirect immunofluorescent antibody method, washed 
with PBS, and used for flow cytometry analysis. 
Flow cytometry measurement 
Rickettsia particles within L929 cells appearing as green 
fluorescence were measured by EPICS Elite flow cytome-
ter (Coulter Corp., Hialeah, FL, USA) and 20,000 cells 
were analyzed to find the fluorescence level of each sam-
ple. The excitation wave length was 488 nm, and data were 
presented as fluorescence intensity, the cellular frequency 
of its log scale. 
Fig. 1. Morphological changes of L929 cells after steroid treatment (phase contrast microscopy, ×100). L929 cells uninfected with Orientia 
tsutsugamushi (A), infected L929 cells (B), and L929 cells treated with dexamethason 10
5 pg/mL (C) after infection were cultured. At 24-hr 
intervals from 24 hr to 96 hr, gross morphology of L929 cells was examined by phase contrast microscopy.
Uninfected L929 cells Infected L929 cells without  
dexamethasone
Infected L929 cells with  
dexamethasone 10
5 pg/mL
A B CEffect of Steroid on Orientia Tsutsugamushi
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er, diverse serotypes are present. Among these, the standard 
serotyes are Gilliam, Karp, and Kato, with various serotypes 
having been reported in different countries. In Korea, Gil-
liam, Karp, and Boryung are the major serotypes, and the 
Boryung serotype has been isolated most abundantly.11 As 
shown by recent clinical studies, the clinical manifestation 
of patients and laboratory results are differ greatly and 
opinions suggesting that this is due to serological differenc-
es have been reported. In the literature, all previous report-
ed deaths were caused by the Gilliam serotype. This sug-
gests the possibility that the severity of clinical manifestation 
is influenced by serotype.12,13 The Gilliam serotype associ-
ated with severe rickettsial disease was used in our experi-
ments because the use of corticosteroids was considered in 
cases suspected to be severe rickettsial disease. Although it 
was not shown in our results, similar results have been ob-
mushi was evaluated by flow cytometry and the results 
showed that differences in the growth of Orientia tsutsuga-
mushi with or without the addition of corticosteroids as well 
as added dosages were not detected (Fig. 3). To evaluate the 
reliability of our results, experiments that assessed the effects 
of interferon on the growth of Orientia tsutsugamushi by 
flow cytometry reported in other studies were used as the 
control group in our study and, similar to the previously re-
ported results, reduction of the growth of Orientia tsutsuga-
mushi in response to interferon-γ administration was con-
firmed (Fig. 4).8 
DISCUSSION
Orientia tsutsugamushi is classified as one species; howev-
Fig. 2. Effect of steroid concentrations on the growth of L929 cells. L929 cells were cultured for 10 days with various concentrations of 
corticosteroids and the number of cells was enumerated. The results showed that during 1-7 days of culture.
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peripheral steroid resistance, etc. Recently, effects on the im-
provement of symptoms, disease duration, and mortality 
have been reported.19 However, in severe sepsis, short-term 
administration of high-dose corticosteroids is not recom-
mended except in cases such as typhoid fever, pneumocysti-
tis carinii pneumonia in acquired immune deficiency syn-
drome, or bacterial encephalomeningitis in children.20 The 
outcome of treatment with corticosteroids in bacterial infec-
tions is difficult to discuss completely. Time of administra-
tion, dosage, maintenance time of corticosteroids as well as 
antibiotics, causative pathogens, and characteristics of the 
infectious disease should be considered. 
In rickettsial diseases, administration of corticosteroids is 
frequently applied to Rocky Mountain Spotted Fever (RMSF) 
that shows ocular symptoms including uveitis, ocular hem-
orrhage, exudate retinosis, etc.21 In addition, it has been re-
ported that in severe RMSF infection accompanying initial 
endotoxemia, hyperazotemia, or hypoproteinemia, cases in 
which cortisone and antibiotics were administered together 
had better treatment outcomes than those cases treated with 
antibiotics alone.5 There have been animal-modeled experi-
ments to show the theoretical basis for this. Because of the 
similarity of diseases between humans and dogs, Rickettsia 
rickettsii infected animal models with the using dogs is a 
proper methodology for human infection research.22 Based 
on recent animal-modeled research on corticosteroid adju-
vant therapy, it has been reported that concurrent use of 
corticosteroids and doxycycline confers no clinically rele-
vant detrimental effects.4 
However, when we tried to apply positive treatment re-
tained in experiments using the Karp serotype. 
For the treatment of scrub typhus, administration of 100 
mg of doxycycline twice a day for 3-7 days is recommend-
ed.14 This treatment has been reported to have excellent re-
sults, and the mortality rate has decreased noticeably from 
50% before use of antibiotics was introduced. Recently, in 
the northern area of Thailand, Orientia tsutsugamushi patho-
gen showing resistance to doxycyclin was isolated and 
showed a tendency of delayed response to antibiotics, but 
this did not raise mortality.15 Although not frequently encoun-
tered, other substitutions could not be suggested for severe 
rickettsial diseases besides antibiotic and conservative treat-
ments. In some patients, progression to severe infection with 
involvement of major organs (such as resulting in encephali-
tis, myocarditis, kidney injury, and interstitial pneumonitis) 
occurred before the antibiotics took effect. Administration of 
corticosteroid to such patients showed inconsistent results.16 
In severe rickettsial disease with immune mediated thrombo-
cytopenia and hemolytic anemia, it is difficult for physicians 
to decide to use corticosteroids at the immunosuppressive 
prednisolone dose (2.0 mg/kg).4
In terms of the use of corticosteroids for bacterial diseas-
es, the most investigated area is septic shock. Prior to the 
1940s, corticosteroid treatment had been administered em-
pirically to severe septic shock patients. Upon summarizing 
the results of clinical studies conducted for the objective 
evaluation of effects, its effects remian unclear.17,18 Despite 
these results, in catecholamine-dependent septic shock, low-
dose corticosteroid treatments have been continuously in-
vestigated because of relative adrenal function deterioration, 
Fig. 4. Effect of IFN-γ on the growth of Orientia tsutsugamushi. To evaluate the stability of our results, experiments that assessed the ef-
fect of interferon-γ on the growth of Orientia tsutsugamushi by flow cytometry were used as the control group.
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Rocky Mountain spotted fever. N Engl J Med 1952;246:962-6. 
6. Choi HC, Wie SH, Lee SY, Kim SI, Park SK, Jung YJ, et al. Use of 
high-dose steroid in a case of scrub typhus with acutely progressive 
local neurologic symptoms. Korean J Infect Dis 2002;34:391-5. 
7. Hansen MB, Nielsen SE, Berg K. Re-examination and further de-
velopment of a precise and rapid dye method for measuring cell 
growth/cell kill. J Immunol Methods 1989;119:203-10. 
8. Tasneen R, Yoshiie K, Ohkawa T, Oda H. High concentration of 
recombinant murine interferon-beta enhances the growth of Ori-
entia (formerly Rickettsia) tsutsugamushi Gilliam in mouse L929 
cells. Acta Virol 1997;41:77-82. 
9. Laffin J, Lehman JM. Detection of intracellular virus and viral 
products. Methods Cell Biol 1990;33:271-84. 
10. Tsuruhara T, Urakami H, Tamura A. Surface morphology of Rick-
ettsia tsutsugamushi-infected mouse fibroblasts. Acta Virol 1982; 
26:506-11. 
11. Chang WH. Occurence of tsutsugamushi disease and prototypes 
of Rickettsia tsutsugamushi in Korea. J Korean Med Assoc 1988; 
31:601-7. 
12. Peck KR, Shin HS, Pai HJ, Chung MH, Oh MD, Song YW, et al. 
A comparative clinical study of scrub typhus seen in rural area and 
at Seoul National University Hospital. Korean J Infect Dis 1991; 
23:155-62. 
13. Choe K. Clinical manifestataions of scub typhus. J Korean Med 
Assoc 1988;31:608-11. 
14. Song JH, Lee C, Chang WH, Choi SW, Choi JE, Kim YS, et al. 
Short-course doxycycline treatment versus conventional tetracy-
cline therapy for scrub typhus: a multicenter randomized trial. Clin 
Infect Dis 1995;21:506-10. 
15. Watt G, Chouriyagune C, Ruangweerayud R, Watcharapichat P, 
Phulsuksombati D, Jongsakul K, et al. Scrub typhus infections 
poorly responsive to antibiotics in northern Thailand. Lancet 1996; 
348:86-9. 
16. Brown GW. Scrub typhus; pathogenesis and clinical syndrome. 
In: Walker DH, editor. Biology of rickettsial disease. Vol 1. Boca 
Raton, FL: CRC Press; 1988. p.93-100. 
17. Lefering R, Neugebauer EA. Steroid controversy in sepsis and 
septic shock: a meta-analysis. Crit Care Med 1995;23:1294-303. 
18. Cronin L, Cook DJ, Carlet J, Heyland DK, King D, Lansang MA, 
et al. Corticosteroid treatment for sepsis: a critical appraisal and 
meta-analysis of the  literature. Crit Care Med 1995;23:1430-9. 
19. Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, et 
al. Stress doses of hydrocortisone reverse hyperdynamic septic 
shock: a prospective, randomized, double-blind, single-center 
study. Crit Care Med 1999;27:723-32. 
20. Annane D. Resurrection of steroids for sepsis resuscitation. Mi-
nerva Anestesiol 2002;68:127-31. 
21. Davidson MG, Breitschwerdt EB, Nasisse MP, Roberts SM. Ocu-
lar manifestations of Rocky Mountain spotted fever in dogs. J Am 
Vet Med Assoc 1989;194:777-81. 
22. Walker DH. The role of host factors in the severity of spotted fe-
ver and typhus rickettsioses. Ann N Y Acad Sci 1990;590:10-9. 
23. Takami A, Yamauchi H, Asakura H, Ishiyama K, Nakao S. Tsutsu-
gamushi disease (scrub typhus)-associated hemophagocytic syn-
drome. Int J Hematol 2002;75:337-8. 
sults from RMSF to scrub typhus, there was one serious 
limitation. We were not able to control the direct risk of 
corticosteroid for the growth of Orientia tsutsugamush, be-
cause it could cause adverse effects. Although one impor-
tant limitation of our study is that in vitro experiments on 
the effects of dexamethasone on cells in culture cannot be 
extrapolated to the complex in vivo situation, our results do 
have meaning in showing that corticosteroid itself does not 
increase the growth of Orientia tsutsugamush, and also in 
reporting that the concurrent use of anti-inflammatory or 
immunosuppressive doses of corticosteroid in conjunction 
with antimicrobials did not lead to adverse influences on 
the course of scrub typhus, because it could not induce bac-
terial growth. Recently, there have been some research into 
the positive effects of corticosteroid in rickettsial disease.6,23 
After this study, more clinical research is needed, such as 
animal model experiments or various experiments to find 
the proper dosages, times and medication duration for corti-
costeroids as treatment for serious rickettsial disease.
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